Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

B of A Securities Downgrades HOOKIPA Pharma to Underperform, Lowers Price Target to $0.5

B of A Securities analyst Alec Stranahan downgrades HOOKIPA Pharma (NASDAQ:HOOK) from Buy to Underperform and lowers the price target from $6 to $0.5.
byBenzinga Newsdesk
December 2, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

B of A Securities analyst Alec Stranahan downgrades HOOKIPA Pharma (NASDAQ:HOOK) from Buy to Underperform and lowers the price target from $6 to $0.5.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts